https://www.avient.com/knowledge-base/article/eco-conscious-alternative-coloring-textiles?ind[]=6600
In addition, Avient has built a strong expertise in spin-dyeing based on decades of developing masterbatch solutions for the textile market and working with local and regional fiber producers and textile associations.
https://www.avient.com/investors/events-presentations?page=12
PolyOne IR Presentation – Fermium Research Marketing Trip – 12/16/2019
PolyOne IR Presentation – KeyBanc Capital Markets Conference – 5/30/2019
Polyone Corporation at KeyBanc Capital Markets Basic Materials and Packaging Conference
https://www.avient.com/investors/events-presentations?page=6
PolyOne IR Presentation – Fermium Research Marketing Trip – 12/16/2019
PolyOne IR Presentation – KeyBanc Capital Markets Conference – 5/30/2019
PolyOne Corporation at KeyBanc Capital Markets Basic Materials & Packaging Conference
https://www.avient.com/investors/events-presentations?page=11
PolyOne IR Presentation – Fermium Research Marketing Trip – 12/16/2019
PolyOne IR Presentation – KeyBanc Capital Markets Conference – 5/30/2019
Polyone Corporation at BB&T Capital Markets Commercial & Industrial Conference
https://www.avient.com/investors/events-presentations?page=10
PolyOne IR Presentation – Fermium Research Marketing Trip – 12/16/2019
PolyOne IR Presentation – KeyBanc Capital Markets Conference – 5/30/2019
Polyone Corporation at Keybanc Capital Markets Basic Materials & Packaging Conference
https://www.avient.com/investors/events-presentations?page=8
PolyOne IR Presentation – Fermium Research Marketing Trip – 12/16/2019
PolyOne IR Presentation – KeyBanc Capital Markets Conference – 5/30/2019
PolyOne Corporation at KeyBanc Capital Markets Basic Materials & Packaging Conference
https://www.avient.com/investors/events-presentations?page=5
PolyOne IR Presentation – Fermium Research Marketing Trip – 12/16/2019
PolyOne IR Presentation – KeyBanc Capital Markets Conference – 5/30/2019
PolyOne Corporation at KeyBanc Capital Markets Basic Materials & Packaging Conference
https://www.avient.com/investor-center/news/polyone-announces-first-quarter-2018-results
Our investments in sales, marketing and technology resources continue to drive our performance," added Mr.
With our invest-to-grow strategy, we better serve new and existing markets and applications, and in doing so, accelerate sales growth and margin expansion for us and our customers."
1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; mark-to-market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results.
https://www.avient.com/news/polyone-announces-first-quarter-2015-results
We also expect to benefit broadly from a recovery in end market demand as raw material prices stabilize."
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: our ability to realize anticipated savings and operational benefits from the realignment of assets, including the closure of manufacturing facilities; the timing of closings and shifts of production to new facilities related to asset realignments and any unforeseen loss of customers and/or disruptions of service or quality caused by such closings and/or production shifts; separation and severance amounts that differ from original estimates; amounts for non-cash charges related to asset write-offs and accelerated depreciation realignments of property, plant and equipment, that differ from original estimates; our ability to identify and evaluate acquisition targets and consummate acquisitions; the ability to successfully integrate acquired companies into our operations, retain the management teams of acquired companies and retain relationships with customers of acquired companies including, without limitation, Spartech Corporation and/or Accella Performance Materials; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability; the speed and extent of an economic recovery, including the recovery of the housing market; our ability to achieve new business gains; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding the disposal of plastic in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions and employee productivity goals; an inability to raise or sustain prices for products or services; an inability to maintain appropriate relations with unions and employees; our ability to continue to pay cash dividends; the amount and timing of repurchases of our common shares, if any; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; employee separation costs resulting from personnel reduction programs, plant phase-in costs, executive separation agreements; asset impairments; mark-to-market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties, remediation costs and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; unrealized gains and losses from foreign currency option contracts; one-time, non-recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results.
https://www.avient.com/investor-center/news/avient-announces-fourth-quarter-and-full-year-2020-results-and-provides-guidance-2021
Adjusted EPS increased 11% to $1.93 pro forma, on strength in healthcare, packaging and consumer end markets
Inventory fair market value step-up expense
Pension settlement/curtailment gains and mark-to-market adjustment